News
It is common practice to restore and maintain sinus rhythm in patients with atrial fibrillation and heart failure. This approach is based in part on data indicating that atrial fibrillation is a ...
78 percent of the patients with congestive heart failure and 84 percent of the controls remained in sinus rhythm (P=0.34) (69 percent and 71 percent, respectively, were in sinus rhythm without the ...
Dr. Al-Khatib told Medscape CRM that because "atrial fibrillation in patients with CHF is associated with a higher mortality, it has been postulated that restoring and maintaining sinus rhythm ...
primarily because of the inability to maintain sinus rhythm. Meanwhile 10% crossed from the rate-control arm to rhythm control, primarily because of worsening heart failure. Hospitalization was ...
"Clinical benefit is observed across the spectrum of heart failure subtypes, suggesting that restoring and maintaining sinus rhythm via rhythm control therapy conveys the clinical benefit," the ...
The AF-CHF trial investigators found that the type ... Furthermore, the proportion of time in sinus rhythm whilst on assigned antiarrhythmia therapy did not effect these outcomes in the 1,316 ...
Researchers at Tampere University have achieved a major milestone in diagnosing heart diseases. According to their new study ...
– For people who have heart failure with a normal heart rhythm, there seems to be little to no advantage of warfarin (an anticoagulant: a medicine which prevents blood clotting by blocking proteins) ...
At baseline, sinus rhythms were recorded more often in patients in the early rhythm control vs standard care group. Catheter ablation was performed among 140 patients with heart failure ...
A sinus arrhythmia refers to a problem with ... It tends to decrease as people age, especially in people living with diabetes or heart failure. Generally, making an effort to maintain a healthy ...
Professor Faiez Zannad, study author, University of Lorraine, Nancy, France, said: "COMMANDER HF is not just another trial of oral anticoagulation in heart failure. The aim is to interfere with ...
CHICAGO, IL—Low-dose rivaroxaban reduces thromboembolic events in patients with worsening heart failure, reduced ejection fraction, CAD, and normal sinus rhythm, a post hoc analysis of the COMMANDER ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results